Most Recent
Canine Cancer Genome Project Enters Phase II -Omics
Focuses genomic and proteomic lenses on three canine cancers
TGen appoints John Fryer, Ph.D., to faculty, further accelerating research innovation in Alzheimer’s, cancer, and other complex diseases
Fryer to serve as professor in the Division of Bioinnovation and Genome Sciences and director of the Center for Accelerated Nanotherapeutics
TGen-ASU study reveals lasting effects of common herbicide on brain health
Glyphosate exposure linked to Alzheimer’s disease-like pathology in pre-clinical models
